Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...

Hims & Hers' Super Bowl ad for unapproved weight loss drugs faces backlash from health experts over safety concerns.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...

Shares of Hims Hers Health (NYSE:HIMS) climbed 3.3% mid-day Monday as the company capitalized on the momentum from its recent ...

Novo Nordisk hit back at telehealth company Hims’ controversial Super Bowl commercial touting cheaper versions of brand-name ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be short-lived deal ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

Hims has a great deal of meme potential, which could benefit the company by effectively acting as free advertising. Read more ...

Trump savages Taylor Swift in fresh social media barrage as president emerges the real Super Bowl winner; What did Taylor Swift say after getting booed at Super Bowl 2025? Lip rea ...

An ad during Sunday night’s Super Bowl has sparked instant controversy. Hims and Hers Health aired a commercial that not only promoted a product but fired ...